Spinocerebellar ataxias: prospects and challenges for therapy development
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Spinocerebellar ataxias: prospects and challenges for therapy development
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 14, Issue 10, Pages 590-605
Publisher
Springer Nature America, Inc
Online
2018-08-21
DOI
10.1038/s41582-018-0051-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurochemical abnormalities in premanifest and early spinocerebellar ataxias
- (2018) James M. Joers et al. ANNALS OF NEUROLOGY
- Ion channel dysfunction in cerebellar ataxia
- (2018) David D. Bushart et al. NEUROSCIENCE LETTERS
- Targeting potassium channels to treat cerebellar ataxia
- (2018) David D. Bushart et al. Annals of Clinical and Translational Neurology
- Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2
- (2017) James M Dell’Orco et al. HUMAN MOLECULAR GENETICS
- The Anti-CRISPR Story: A Battle for Survival
- (2017) Karen L. Maxwell MOLECULAR CELL
- The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit
- (2017) Karthik Murugan et al. MOLECULAR CELL
- CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
- (2017) Alex Mas Monteys et al. MOLECULAR THERAPY
- Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
- (2017) Daniel R. Scoles et al. NATURE
- Polyglutamine tracts regulate beclin 1-dependent autophagy
- (2017) Avraham Ashkenazi et al. NATURE
- Refining strategies to translate genome editing to the clinic
- (2017) Tatjana I Cornu et al. NATURE MEDICINE
- Polyglutamine spinocerebellar ataxias — from genes to potential treatments
- (2017) Henry L. Paulson et al. NATURE REVIEWS NEUROSCIENCE
- Class 2 CRISPR–Cas RNA-guided endonucleases: Swiss Army knives of genome editing
- (2017) Stefano Stella et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia
- (2017) Ilaria Giordano et al. NEUROLOGY
- Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome
- (2017) Chantal Sellier et al. NEURON
- Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31
- (2017) Taro Ishiguro et al. NEURON
- Identification of early neurodegenerative change in presymptomatic spinocerebellar ataxia type 1: A diffusion tensor imaging study
- (2017) Yeon Ji Yoo et al. PARKINSONISM & RELATED DISORDERS
- Class 2 CRISPR–Cas RNA-guided endonucleases: Swiss Army knives of genome editing
- (2017) Stefano Stella et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
- (2017) Lodewijk J.A. Toonen et al. Molecular Therapy-Nucleic Acids
- Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
- (2017) Lauren R. Moore et al. Molecular Therapy-Nucleic Acids
- Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
- (2017) Adriano M. de Assis et al. Frontiers in Neurology
- Inheritance patterns of ATCCT repeat interruptions in spinocerebellar ataxia type 10 (SCA10) expansions
- (2017) Ivette Landrian et al. PLoS One
- RNAi prevents and reverses phenotypes induced by mutant human ataxin-1
- (2016) Megan S. Keiser et al. ANNALS OF NEUROLOGY
- ATXN2-AS, a gene antisense toATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis
- (2016) Pan P. Li et al. ANNALS OF NEUROLOGY
- Repeat-associated non-AUG translation from antisense CCG repeats in fragile X tremor/ataxia syndrome
- (2016) Amy Krans et al. ANNALS OF NEUROLOGY
- Diminishing return for mechanistic therapeutics with neurodegenerative disease duration?
- (2016) David C. Rubinsztein et al. BIOESSAYS
- Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3
- (2016) Maria do Carmo Costa et al. BRAIN
- Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6
- (2016) Nyeonju Kang et al. Brain Structure & Function
- Local Stability of the Trunk in Patients with Degenerative Cerebellar Ataxia During Walking
- (2016) Giorgia Chini et al. CEREBELLUM
- Parametric fMRI of paced motor responses uncovers novel whole-brain imaging biomarkers in spinocerebellar ataxia type 3
- (2016) João Valente Duarte et al. HUMAN BRAIN MAPPING
- Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3β-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1)
- (2016) Ivelisse Sánchez et al. HUMAN MOLECULAR GENETICS
- In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model
- (2016) Polina A. Egorova et al. JOURNAL OF NEUROPHYSIOLOGY
- Prolonged Type 1 Metabotropic Glutamate Receptor Dependent Synaptic Signaling Contributes to Spino-Cerebellar Ataxia Type 1
- (2016) Emmet M. Power et al. JOURNAL OF NEUROSCIENCE
- Modulation of Molecular Chaperones in Huntington’s Disease and Other Polyglutamine Disorders
- (2016) Sara D. Reis et al. MOLECULAR NEUROBIOLOGY
- Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials
- (2016) Roberto Rodríguez-Labrada et al. MOVEMENT DISORDERS
- Individual changes in preclinical spinocerebellar ataxia identified via increased motor complexity
- (2016) Winfried Ilg et al. MOVEMENT DISORDERS
- Rare neurological channelopathies — networks to study patients, pathogenesis and treatment
- (2016) Joanna C. Jen et al. Nature Reviews Neurology
- Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients
- (2016) Mafalda Raposo et al. NEUROMOLECULAR MEDICINE
- BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1
- (2016) Ying Ding et al. NEUROSCIENCE
- Validity of a wearable accelerometer to quantify gait in spinocerebellar ataxia type 6
- (2016) Aodhán Hickey et al. PHYSIOLOGICAL MEASUREMENT
- An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron
- (2016) Yu Miyazaki et al. Science Translational Medicine
- Activity-Dependent Plasticity of Spike Pauses in Cerebellar Purkinje Cells
- (2016) Giorgio Grasselli et al. Cell Reports
- Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment
- (2016) Isabel Onofre et al. Scientific Reports
- 4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6
- (2016) Sriram Jayabal et al. Scientific Reports
- Progression of Microstructural Damage in Spinocerebellar Ataxia Type 2: A Longitudinal DTI Study
- (2015) M. Mascalchi et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Cycling Regimen Induces Spinal Circuitry Plasticity and Improves Leg Muscle Coordination in Individuals With Spinocerebellar Ataxia
- (2015) Ya-Ju Chang et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Analysis of SCA8, SCA10, SCA12, SCA17 and SCA19 in patients with unknown spinocerebellar ataxia: a Thai multicentre study
- (2015) Lulin Choubtum et al. BMC Neurology
- Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease
- (2015) Andreia Teixeira-Castro et al. BRAIN
- Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3
- (2015) Gerson da Silva Carvalho et al. CEREBELLUM
- Early Cerebellar Network Shifting in Spinocerebellar Ataxia Type 6
- (2015) M.I. Falcon et al. CEREBRAL CORTEX
- Cerebrospinal Fluid Biomarkers in Spinocerebellar Ataxia: A Pilot Study
- (2015) Ashley M. Brouillette et al. DISEASE MARKERS
- DnaJ-1 and karyopherin α3 suppress degeneration in a newDrosophilamodel of Spinocerebellar Ataxia Type 6
- (2015) Wei-Ling Tsou et al. HUMAN MOLECULAR GENETICS
- Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia
- (2015) Megan S. Keiser et al. HUMAN MOLECULAR GENETICS
- An investigation of diffusion imaging techniques in the evaluation of spinocerebellar ataxia and multisystem atrophy
- (2015) Michael N. Rozenfeld et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial
- (2015) Jonas Alex Morales Saute et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
- (2015) Silvia Romano et al. LANCET NEUROLOGY
- Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study
- (2015) Heike Jacobi et al. LANCET NEUROLOGY
- Test-retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3T and 7T
- (2015) Melissa Terpstra et al. MAGNETIC RESONANCE IN MEDICINE
- In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7
- (2015) Isaac M. Adanyeguh et al. MOVEMENT DISORDERS
- Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: Comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology
- (2015) Gülin Öz et al. NEUROBIOLOGY OF DISEASE
- The preclinical stage of spinocerebellar ataxias
- (2015) Roderick P.P.W.M. Maas et al. NEUROLOGY
- Multi-center reproducibility of neurochemical profiles in the human brain at 7 T
- (2015) B. L. van de Bank et al. NMR IN BIOMEDICINE
- SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure
- (2015) Karen N. McFarland et al. PLoS One
- Repeat Associated Non-AUG Translation (RAN Translation) Dependent on Sequence Downstream of the ATXN2 CAG Repeat
- (2015) Daniel R. Scoles et al. PLoS One
- The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice
- (2014) Sandro Alves et al. ACTA NEUROPATHOLOGICA
- Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes
- (2014) Sophie Tezenas du Montcel et al. BRAIN
- Executive deficit in spinocerebellar ataxia type 2 is related to expanded CAG repeats: Evidence from antisaccadic eye movements
- (2014) Roberto Rodríguez-Labrada et al. BRAIN AND COGNITION
- EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood
- (2014) B. P. C. van de Warrenburg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Gait adaptability training improves obstacle avoidance and dynamic stability in patients with cerebellar degeneration
- (2014) Ella M.R. Fonteyn et al. GAIT & POSTURE
- Role of glutathione S-transferases in the spinocerebellar ataxia type 2 clinical phenotype
- (2014) D. Almaguer-Gotay et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T
- (2014) Dinesh K. Deelchand et al. MAGNETIC RESONANCE IN MEDICINE
- Broad Therapeutic Benefit After RNAi Expression Vector Delivery to Deep Cerebellar Nuclei: Implications for Spinocerebellar Ataxia Type 1 Therapy
- (2014) Megan S Keiser et al. MOLECULAR THERAPY
- Nonallele Specific Silencing of Ataxin-7 Improves Disease Phenotypes in a Mouse Model of SCA7
- (2014) Pavitra S Ramachandran et al. MOLECULAR THERAPY
- The APOE ε2 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population
- (2014) Huirong Peng et al. NEUROBIOLOGY OF AGING
- The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies
- (2014) Luis Ruano et al. NEUROEPIDEMIOLOGY
- NINDS Translational Programs: Priming the Pump of Neurotherapeutics Discovery and Development
- (2014) Rajesh Ranganathan NEURON
- Oligonucleotide-based strategies to combat polyglutamine diseases
- (2014) A. Fiszer et al. NUCLEIC ACIDS RESEARCH
- RNA Interference Mitigates Motor and Neuropathological Deficits in a Cerebellar Mouse Model of Machado-Joseph Disease
- (2014) Clévio Nóbrega et al. PLoS One
- Clinical Proton MR Spectroscopy in Central Nervous System Disorders
- (2014) Gülin Öz et al. RADIOLOGY
- Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6
- (2013) Kathrin Reetz et al. BRAIN
- Expression of Expanded CAG Transcripts Triggers Nucleolar Stress in Huntington's Disease
- (2013) Ho Tsoi et al. CEREBELLUM
- Consensus Paper: Management of Degenerative Cerebellar Disorders
- (2013) W. Ilg et al. CEREBELLUM
- Spinocerebellar Ataxias in Brazil—Frequencies and Modulating Effects of Related Genes
- (2013) Raphael Machado de Castilhos et al. CEREBELLUM
- Optical coherence tomography findings in spinocerebellar ataxia-3
- (2013) G Alvarez et al. EYE
- Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1
- (2013) Uzay E. Emir et al. JOURNAL OF NEUROCHEMISTRY
- Experience in a short-term trial with 4-Aminopyridine in cerebellar ataxia
- (2013) I. Giordano et al. JOURNAL OF NEUROLOGY
- The effectiveness of allied health care in patients with ataxia: a systematic review
- (2013) Ella M. R. Fonteyn et al. JOURNAL OF NEUROLOGY
- Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data
- (2013) Heike Jacobi et al. LANCET NEUROLOGY
- Toward RNAi Therapy for the Polyglutamine Disease Machado–Joseph Disease
- (2013) Maria do Carmo Costa et al. MOLECULAR THERAPY
- Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice
- (2013) Edgardo Rodríguez-Lebrón et al. MOLECULAR THERAPY
- A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3
- (2013) Rachel P. Guimarães et al. MOVEMENT DISORDERS
- RAS–MAPK–MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1
- (2013) Jeehye Park et al. NATURE
- Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures
- (2013) Karen N. McFarland et al. NEUROGENETICS
- Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study
- (2013) Tetsuo Ashizawa et al. Orphanet Journal of Rare Diseases
- Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
- (2013) Serena Notartomaso et al. Molecular Brain
- Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model
- (2013) Mimi Cushman-Nick et al. PLoS Genetics
- The Role of Interruptions in polyQ in the Pathology of SCA1
- (2013) Rajesh P. Menon et al. PLoS Genetics
- Factors Influencing Disease Progression in Autosomal Dominant Cerebellar Ataxia and Spastic Paraplegia
- (2012) Perrine Charles ARCHIVES OF NEUROLOGY
- Magnetic Resonance Imaging Biomarkers in Patients with Progressive Ataxia: Current Status and Future Direction
- (2012) Stuart Currie et al. CEREBELLUM
- Selective Positive Modulator of Calcium-Activated Potassium Channels Exerts Beneficial Effects in a Mouse Model of Spinocerebellar Ataxia Type 2
- (2012) Adebimpe W. Kasumu et al. CHEMISTRY & BIOLOGY
- Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7
- (2012) S. A. Furrer et al. HUMAN MOLECULAR GENETICS
- Cerebellar Ataxia by Enhanced CaV2.1 Currents Is Alleviated by Ca2+-Dependent K+-Channel Activators in Cacna1aS218L Mutant Mice
- (2012) Z. Gao et al. JOURNAL OF NEUROSCIENCE
- Video game-based coordinative training improves ataxia in children with degenerative ataxia
- (2012) W. Ilg et al. NEUROLOGY
- SK2 Channel Modulation Contributes to Compartment-Specific Dendritic Plasticity in Cerebellar Purkinje Cells
- (2012) Gen Ohtsuki et al. NEURON
- Spinocerebellar Ataxia Types 1, 2, 3 and 6: the Clinical Spectrum of Ataxia and Morphometric Brainstem and Cerebellar Findings
- (2011) Heike Jacobi et al. CEREBELLUM
- Ataxia Rating Scales—Psychometric Profiles, Natural History and Their Application in Clinical Trials
- (2011) Jonas Alex Morales Saute et al. CEREBELLUM
- Quantification of Circulating Plasma DNA in Friedreich's Ataxia and Spinocerebellar Ataxia Types 2 and 12
- (2011) Vishnu Swarup et al. DNA AND CELL BIOLOGY
- In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
- (2011) Gülin Öz et al. EXPERIMENTAL NEUROLOGY
- Genes and pathways affected by CAG-repeat RNA-based toxicity in Drosophila
- (2011) Shin-Yi Shieh et al. HUMAN MOLECULAR GENETICS
- Ataxin-2 repeat-length variation and neurodegeneration
- (2011) O. A. Ross et al. HUMAN MOLECULAR GENETICS
- Neocortical Atrophy in Machado-Joseph Disease: A Longitudinal Neuroimaging Study
- (2011) Anelyssa D’Abreu et al. JOURNAL OF NEUROIMAGING
- Aminopyridines Correct Early Dysfunction and Delay Neurodegeneration in a Mouse Model of Spinocerebellar Ataxia Type 1
- (2011) R. Hourez et al. JOURNAL OF NEUROSCIENCE
- SK2 channel expression and function in cerebellar Purkinje cells
- (2011) Eric Hosy et al. JOURNAL OF PHYSIOLOGY-LONDON
- Saccadic latency is prolonged in Spinocerebellar Ataxia type 2 and correlates with the frontal-executive dysfunctions
- (2011) Roberto Rodríguez-Labrada et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Objective home-based gait assessment in spinocerebellar ataxia
- (2011) S.H. Subramony et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias
- (2011) Ellis Chan et al. MOVEMENT DISORDERS
- Retinal Nerve Fibre Layer and Macular Thinning in Spinocerebellar Ataxia and Cerebellar Multisystem Atrophy
- (2011) John H. Pula et al. NEURO-OPHTHALMOLOGY
- Sleep Disorders in Spinocerebellar Ataxia Type 2 Patients
- (2011) Luis Velázquez-Pérez et al. Neurodegenerative Diseases
- A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias
- (2011) M. Strupp et al. NEUROLOGY
- CTCF Regulates Ataxin-7 Expression through Promotion of a Convergently Transcribed, Antisense Noncoding RNA
- (2011) Bryce L. Sopher et al. NEURON
- Hereditary ataxias and paraplegias in Valle ďAosta, Italy: a study of prevalence and disability
- (2010) M. Leone et al. ACTA NEUROLOGICA SCANDINAVICA
- Occupational therapy in spinocerebellar ataxia type 3: an open-label trial
- (2010) R.C.R. Silva et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Loss of Intrinsic Organization of Cerebellar Networks in Spinocerebellar Ataxia Type 1: Correlates with Disease Severity and Duration
- (2010) Ana Solodkin et al. CEREBELLUM
- Distinct Neurochemical Profiles of Spinocerebellar Ataxias 1, 2, 6, and Cerebellar Multiple System Atrophy
- (2010) Gülin Öz et al. CEREBELLUM
- Induction of Molecular Chaperones as a Therapeutic Strategy for the Polyglutamine Diseases
- (2010) Yoshitaka Nagai et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Silencing ataxin-3 mitigates degeneration in a rat model of Machado–Joseph disease: no role for wild-type ataxin-3?
- (2010) Sandro Alves et al. HUMAN MOLECULAR GENETICS
- Noninvasive Detection of Presymptomatic and Progressive Neurodegeneration in a Mouse Model of Spinocerebellar Ataxia Type 1
- (2010) G. Oz et al. JOURNAL OF NEUROSCIENCE
- Excessive daytime somnolence in spinocerebellar ataxia type 1
- (2010) Dien Dang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Progression markers of Spinocerebellar Ataxia 2. A twenty years neurophysiological follow up study
- (2010) Luis Velázquez-Perez et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Subtle rapid eye movement sleep abnormalities in presymptomatic spinocerebellar ataxia type 2 gene carriers
- (2010) Roberto Rodríguez-Labrada et al. MOVEMENT DISORDERS
- Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status
- (2010) Gülin Öz et al. MOVEMENT DISORDERS
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
- (2010) Andrew C. Elden et al. NATURE
- Responsiveness of different rating instruments in spinocerebellar ataxia patients
- (2010) T. Schmitz-Hubsch et al. NEUROLOGY
- Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial
- (2010) G. Ristori et al. NEUROLOGY
- Non-ATG-initiated translation directed by microsatellite expansions
- (2010) T. Zu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Partial Loss of Ataxin-1 Function Contributes to Transcriptional Dysregulation in Spinocerebellar Ataxia Type 1 Pathogenesis
- (2010) Juan Crespo-Barreto et al. PLoS Genetics
- Periodic Alternating Nystagmus and Periodic Alternating Skew Deviation in Spinocerebellar Ataxia Type 6
- (2009) Chaim B Colen et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2
- (2009) J. Liu et al. JOURNAL OF NEUROSCIENCE
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
- (2009) Andrew D Goodman et al. LANCET
- Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS
- (2009) Jeremy D. Schmahmann et al. MOVEMENT DISORDERS
- Continuous base identification for single-molecule nanopore DNA sequencing
- (2009) James Clarke et al. Nature Nanotechnology
- Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes
- (2009) Neal Prakash et al. NEUROIMAGE
- Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6
- (2009) Jörg B. Schulz et al. NEUROIMAGE
- Intensive coordinative training improves motor performance in degenerative cerebellar disease
- (2009) W. Ilg et al. NEUROLOGY
- Cerebellar stroke without motor deficit: clinical evidence for motor and non-motor domains within the human cerebellum
- (2009) J.D. Schmahmann et al. NEUROSCIENCE
- Motor Decline in Clinically Presymptomatic Spinocerebellar Ataxia Type 2 Gene Carriers
- (2009) Luis Velázquez-Perez et al. PLoS One
- Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment
- (2008) Sophie Tezenas du Montcel et al. BRAIN
- The clinical diagnosis of autosomal dominant spinocerebellar ataxias
- (2008) Thomas Klockgether CEREBELLUM
- Bidirectional expression of the SCA8 expansion mutation: One mutation, two genes
- (2008) Yoshio Ikeda et al. CEREBELLUM
- Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1
- (2008) Antoni Matilla-Dueñas et al. CEREBELLUM
- A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3)
- (2008) C. Kieling et al. EUROPEAN JOURNAL OF NEUROLOGY
- Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1
- (2008) Huda Y. Zoghbi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3
- (2008) X. Chen et al. JOURNAL OF NEUROSCIENCE
- RNA toxicity is a component of ataxin-3 degeneration in Drosophila
- (2008) Ling-Bo Li et al. NATURE
- In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis
- (2008) Aislinn J. Williams et al. NEUROBIOLOGY OF DISEASE
- Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics
- (2008) Riccardo Della Nave et al. NEUROIMAGE
- SCA Functional Index: A useful compound performance measure for spinocerebellar ataxia
- (2008) T. Schmitz-Hubsch et al. NEUROLOGY
- Intrafamilial variability of Parkinson phenotype in SCAs: Novel cases due to SCA2 and SCA3 expansions
- (2008) M.P. Socal et al. PARKINSONISM & RELATED DISORDERS
- Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease
- (2008) Sandro Alves et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started